Abstract:Objective: To investigate the osteogenic differentiation potential and the biological features of synovium-derived mesenchymal stem cells (SMSCs) in vitro and to observe the osteogenic capability of the composite scaffolds constructed with SMSCs and hydroxylapatite/chitosan/poly L-latic acid (HA/CS/PLLA) in vivo. Methods: SMSCs were separated and cultured with adherent method and enzymatic digestion method. Specific phenotypes of SMSCs were detected by flow cytometry after purification. Then, SMSCs were identified by oil red O staining, alkaline phosphatase (ALP) staining, and alizarin red staining after adipogenic and osteogenic induction, respectively. In vitro experiments: the expressions of osteogenic related genes [osteocalcin (OCN), collagen type I, ALP, and Runx-2] were detected by real-time fluorescent quantitative PCR at 1, 7, 14, 21, and 28 days after osteogenic induction; ALP activities were also determined by ELISA at 1, 3, 5, 7, 9, and 11 days after osteogenic induction; meanwhile, extracellular matrix calcium mineralization was detected by alizarin red S method at 7, 14, 21, and 28 days after osteogenic induction; the normal SMSCs were harvested as control group. In vivo experiments: Twenty-four Sprague Dawley (SD) rats were randomly divided into experimental group (n = 12) and control group (n = 12). The 3rd passage SMSCs were seeded on HA/CS/PLLA to construct composite scaffolds, after adhesion for 72 hours in vitro, the composite scaffolds were implanted into the right thigh muscle of 12 SD rats as experimental group; HA/CS/PLLA was implanted into the right thigh muscle of the other 12 SD rats as control group. At 4 and 8 weeks after implantation, the scaffolds were harvested for X-ray film and histological examination to observe ectopic bone formation. Results: The positive rates of CD147, CD90, CD105, and CD44 were more than 95%, while the positive rates of CD117, CD34, CD14, and CD45 were less than 10%. Oil red O staining demonstrated red lipid droplets in the cytoplasm, and alizarin red staining showed flaky red calcifications, and cytoplasm was dyed brown by the ALP staining. The mRNA expressions of collagen type I, ALP, and Runx-2 were significantly increased at 7 days after osteogenic induction, and OCN mRNA expression was significantly increased at 14 days after osteogenic induction; ALP activity was significantly higher at 5, 7, 9, 11 days after osteogenic induction in the SMSC-induced group than control group and reached a maximum at 7 days (P < 0.05). Calcium mineralization was significantly enhanced at 14 days after osteogenic induction, and gradually increased with time (P < 0.05); moreover, it was significantly higher in the SMSC-induced group than control group (P < 0.05). X-ray and histological examination demonstrated that the new bone tissues formed in 2 groups, but bone formation content of the experimental group was significantly more than that of the control group at 4 and 8 weeks after implantation (P < 0.05). Conclusion: SMSCs can be induced into osteoblasts both in vitro and in vivo, so SMSCs might be a promising seed cells for bone tissue engineering.

Ectopic Osteogenesis and Scaffold Biodegradation of Tissue Engineering Bone Composed of Chitosan and Osteo-Induced Bone Marrow Mesenchymal Stem Cells in Vivo

Ectopic osteogenesis and scaffold biodegradation of nano-hydroxyapatite-chitosan in a rat model

Engineering Scaffolds Integrated with Calcium Sulfate and Oyster Shell for Enhanced Bone Tissue Regeneration

Silk Fibroin/chitosan Scaffold with Tunable Properties and Low Inflammatory Response Assists the Differentiation of Bone Marrow Mesenchymal Stem Cells.

The Use of Injectable Chitosan/Nanohydroxyapatite/collagen Composites with Bone Marrow Mesenchymal Stem Cells to Promote Ectopic Bone Formation in Vivo

Chitosan Composite Scaffold Combined with Bone Marrow-Derived Mesenchymal Stem Cells for Bone Regeneration: in Vitro and in Vivo Evaluation

Ectopic Osteogenesis and Chondrogenesis of Bone Marrow Stromal Stem Cells in Alginate System

[EXPERIMENTAL STUDY ON OSTEOGENESIS OF SYNOVIUM-DERIVED MESENCHYMAL STEM CELLS IN VITRO AND IN VIVO]

Microarchitectural and mechanical characterization of chitosan/hydroxyapatite/demineralized bone matrix composite scaffold

A silk fibroin/chitosan/nanohydroxyapatite biomimetic bone scaffold combined with autologous concentrated growth factor promotes the proliferation and osteogenic differentiation of BMSCs and repair of critical bone defects

Oxidized Bacterial Cellulose Reinforced Nanocomposite Scaffolds for Bone Repair

Strontium-substituted calcium sulfate hemihydrate/hydroxyapatite scaffold enhances bone regeneration by recruiting bone mesenchymal stromal cells

Mechanically enhanced composite hydrogel scaffold for in situ bone repairs

Biocompatible octacalcium phosphate/sodium alginate/silk fibroin composite scaffolds for bone regeneration

In Vitro Biocompatibility and Osteoblast Differentiation of an Injectable Chitosan/Nano-Hydroxyapatite/Collagen Scaffold

A Novel Biomimetic Composite Scaffold Hybridized with Mesenchymal Stem Cells in Repair of Rat Bone Defects Models

Biomimetic mineralization of carboxymethyl chitosan nanofibers with improved osteogenic activity in vitro and in vivo.

Bone Tissue Engineering Scaffold Optimisation through Modification of Chitosan/Ceramic Composition

Feasibility of chitosan-calcium phosphate cement/recombinant human bone morphogenetic protein-2 composite scaffold co-cultured with bone marrow mesenchymal stem cells after induction

Experimental study on Bio-Oss /PRF and BMSCs composite scaffold in tissue-engineered bone

Zero-order controlled release of BMP2-derived peptide P24 from the chitosan scaffold by chemical grafting modification technique for promotion of osteogenesis in vitro and enhancement of bone repair in vivo